• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Oncothyreon Inc

+ Add to Watchlist

ONTY:US

2.8900 USD 0.0100 0.35%

As of 20:10:00 ET on 07/30/2014.

Company Profile for Oncothyreon Inc (ONTY)

Oncothyreon Inc. develops therapeutic approaches to cancer management. The Company focuses on the development of synthetic vaccines and strategies for immunotherapy of cancer. Oncothyreon delivers its services to customers throughout the United States.

Contact Information

Oncothyreon Inc

2601 Fourth Avenue Suite 500
Seattle, WA 98121
United States
Phone: 1-206-801-2100
Fax: 1-206-801-2101

Key Executives for Oncothyreon Inc (ONTY)

Robert L KirkmanPresident/CEOGary ChristiansonChief Operating Officer
Diana HausmanChief Medical OfficerScott PetersonChief Scientific Officer
Julia M EastlandVP:Corporate Dev/CFO/SecyJane TullochDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil